Drug Approval | March 21, 2022
Alembic Pharmaceuticals receives USFDA approval for Lacosamide tablets
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
The tablets are indicated for the treatment of partial-onset seizures in patients 4 years of age and older
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The generic version of Sinequan, which is used for the treatment of anxiety, depression, and other target symptoms of psychoneurosis
EUROAPI listing on Euronext Paris will occur in H1 2022, despite volatile market conditions
DASH enables non-laboratory personnel to insert a nasal swab specimen directly into our test cartridge and then load the cartridge into the DASH instrument, providing an accurate result in about 15 minutes
If the government feels that the industry is not complying with the uniform code, it will consider making it a statutory code
Srichakra receives European Food Safety approval for its food-grade recycled rPET
This is the sixth successful USFDA audit for this facility
The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
Subscribe To Our Newsletter & Stay Updated
